bbi-biotech

bbi-biotech

Berlin, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

bbi-biotech is a privately held German equipment provider, established in 2000 (with a founding note of 2009 for the GmbH), that designs and manufactures bioreactors, fermenters, and the proprietary bioPROBE automated sampling technology. The company targets the high-growth microbiome and biologics sectors, offering solutions from benchtop to 10,000-liter scale with a business model centered on selling hardware, systems, and consumables/accessories. It is a revenue-generating entity competing in the global bioprocessing equipment market, differentiated by its focus on customization and sterility.

MicrobiomeBiologics

Technology Platform

Hardware platform for bioprocessing, including bioreactors/fermenters (xCUBIO line), automated sampling (bioPROBE), and clean steam generation systems.

Opportunities

The global expansion of biologics and microbiome research drives demand for scalable fermentation capacity.
The industry's shift towards automation and data integrity creates a specific opportunity for bbi-biotech's bioPROBE sampling technology and advanced control systems.

Risk Factors

Faces intense competition from large, well-capitalized multinational equipment suppliers.
Revenue is cyclical and dependent on the capital expenditure health of the biopharma sector.
Supply chain disruptions for critical components could impact production and margins.

Competitive Landscape

Operates in a competitive market dominated by giants like Sartorius, Thermo Fisher Scientific, and Merck KGaA. bbi-biotech differentiates through high customization, a focus on sterility, and niche innovations like the bioPROBE. It competes as a specialized, quality-focused alternative to broader portfolio suppliers.